Marshall Devor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marshall Devor has a total of 235 co-authors. Here are the top co-authors by number of shared publications:
Anne Minert
Department of Cell and Developmental Biology, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel
11 shared publications- Anne Minert
Department of Cell and Developmental Biology, Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Safra Givat Ram Campus, Jerusalem 9190401, Israel
8 shared publications - Mark Baron
Department of Cell and Developmental Biology, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel
8 shared publications Mark Baron
Department of Cell and Developmental Biology, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel
5 shared publicationsShai-Lee Yatziv
Department of Cell and Developmental Biology, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel
5 shared publicationsRon Amir
Department of Cell and Animal Biology, Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem 91904, Israel
4 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by SAGE Publications in The Neuroscientist
Brainstem Theory of Consciousness
The brainstem theory of consciousness asserts that raw, subjective experience, the “me inside,” derives from computations implemented in the brainstem, not the cortex. The argument rests on philosophy’s prototypical example of sentience, pain. Feeling pain does not require cortical processing. Nowhere in the cortex does electrical stimulation reliably evoke pain. Subcortical stimulation does. Painful epileptic seizures are rare. Cortical lesions do not eliminate pain or cause loss of consciousness (LOC). Indeed, some individuals with near-complete cortical loss are sentient. Focal brainstem lesions, however, often cause LOC/coma, as do anesthetics delivered to these same foci (general anesthesia). Clearly, peripheral nociceptor input can be translated into conscious pain experience by the “primitive” brainstem. Fish and reptiles respond to threats using vision, sound, and olfaction, but this capacity is rudimentary. Except for pain, advanced sensory feature extraction requires the supercomputer-like capacity of the mammalian cerebral cortex, available evolutionarily only eons after reptiles. Rather than reinventing sentience circuitry with cortical architecture, evolution exploited the sentience-of-pain capability long functioning in the brainstem with the aid of dedicated axonal pathways. This explains why large cortical lesions disrupt “consciousness of” specific things, without causing unconsciousness, while focal brainstem lesions erase all sentience, including pain, sending the individual into oblivion.
- 25 August 2026
- Published by SAGE Publications in The Neuroscientist
Open AccessBrainstem Theory of Consciousness
The brainstem theory of consciousness asserts that raw, subjective experience, the “me inside,” derives from computations implemented in the brainstem, not the cortex. The argument rests on philosophy’s prototypical example of sentience, pain. Feeling pain does not require cortical processing. Nowhere in the cortex does electrical stimulation reliably evoke pain. Subcortical stimulation does. Painful epileptic seizures are rare. Cortical lesions do not eliminate pain or cause loss of consciousness (LOC). Indeed, some individuals with near-complete cortical loss are sentient. Focal brainstem lesions, however, often cause LOC/coma, as do anesthetics delivered to these same foci (general anesthesia). Clearly, peripheral nociceptor input can be translated into conscious pain experience by the “primitive” brainstem. Fish and reptiles respond to threats using vision, sound, and olfaction, but this capacity is rudimentary. Except for pain, advanced sensory feature extraction requires the supercomputer-like capacity of the mammalian cerebral cortex, available evolutionarily only eons after reptiles. Rather than reinventing sentience circuitry with cortical architecture, evolution exploited the sentience-of-pain capability long functioning in the brainstem with the aid of dedicated axonal pathways. This explains why large cortical lesions disrupt “consciousness of” specific things, without causing unconsciousness, while focal brainstem lesions erase all sentience, including pain, sending the individual into oblivion.
- Open Access
- 24 November 2025
- Published by MDPI AG in Anesthesia Research
- Vol. 2 (4) , 26
Axonal Projections of Neurons in the Brainstem Mesopontine Tegmental Anesthesia Area (MPTA) That Effect Anesthesia, Enabling Pain-Free Surgery
Background/Objectives: Chemogenetic excitation of a distinct subset of “effector-neurons” in the brainstem mesopontine tegmental anesthesia area (MPTA) is pro-anesthetic. GABAergic general anesthetics are believed to engage these neurons by disinhibition, thereby inducing loss-of-consciousness (LOC) and enabling pain-free surgery. The transition from wakefulness to LOC, however, does not occur intrinsically within the MPTA. Rather, evidence indicates that LOC is brought about (effected) by ascending and descending axonal projections of MPTA effector-neurons that terminate in a variety of downstream brain targets which, together, generate the various components of anesthesia. Previously we used anterograde and retrograde tracing to delineate the overall axonal trajectories of MPTA projection-neurons, to which targets they project. Effector-neurons, however, represent only a fraction of this neuronal pool. Which of these targets are also innervated by MPTA projecting effector-neurons? Methods: Here we marked MPTA effector-neurons with the adeno-associated virus (AAV) used in the discovery of this neuronal type, with retrograde labelling from the previously identified MPTA target structures, to establish which downstream brain structures receive direct input from effector-neurons. Results: Effector-neurons proved to contribute to all six of the major MPTA projection-targets: the prefrontal cortex, basal forebrain, intralaminar thalamus, zona incerta, rostro-ventromedial medulla and spinal cord. Conclusions: We conclude that a discrete population of projecting effector-neurons, probably representing only about 6% of all MPTA neurons, drive the multiple functional endpoints of surgical anesthesia: analgesia, atonia, amnesia and LOC. Further, we propose that these same neurons, via their associated axonal pathways, may also contribute to endogenous instances of LOC such as natural sleep, fainting, concussion, coma and hibernation.
- 24 November 2025
- Published by MDPI AG in Anesthesia Research
- Vol. 2 (4) , 26
Open AccessAxonal Projections of Neurons in the Brainstem Mesopontine Tegmental Anesthesia Area (MPTA) That Effect Anesthesia, Enabling Pain-Free Surgery
Background/Objectives: Chemogenetic excitation of a distinct subset of “effector-neurons” in the brainstem mesopontine tegmental anesthesia area (MPTA) is pro-anesthetic. GABAergic general anesthetics are believed to engage these neurons by disinhibition, thereby inducing loss-of-consciousness (LOC) and enabling pain-free surgery. The transition from wakefulness to LOC, however, does not occur intrinsically within the MPTA. Rather, evidence indicates that LOC is brought about (effected) by ascending and descending axonal projections of MPTA effector-neurons that terminate in a variety of downstream brain targets which, together, generate the various components of anesthesia. Previously we used anterograde and retrograde tracing to delineate the overall axonal trajectories of MPTA projection-neurons, to which targets they project. Effector-neurons, however, represent only a fraction of this neuronal pool. Which of these targets are also innervated by MPTA projecting effector-neurons? Methods: Here we marked MPTA effector-neurons with the adeno-associated virus (AAV) used in the discovery of this neuronal type, with retrograde labelling from the previously identified MPTA target structures, to establish which downstream brain structures receive direct input from effector-neurons. Results: Effector-neurons proved to contribute to all six of the major MPTA projection-targets: the prefrontal cortex, basal forebrain, intralaminar thalamus, zona incerta, rostro-ventromedial medulla and spinal cord. Conclusions: We conclude that a discrete population of projecting effector-neurons, probably representing only about 6% of all MPTA neurons, drive the multiple functional endpoints of surgical anesthesia: analgesia, atonia, amnesia and LOC. Further, we propose that these same neurons, via their associated axonal pathways, may also contribute to endogenous instances of LOC such as natural sleep, fainting, concussion, coma and hibernation.
- 3 November 2025
- Published by Cambridge University Press (CUP) in Behavioral and Brain Sciences
- Vol. 48, e80
Pain and the evolutionary origins of subjective experience
The cerebral neocortex is essential for the complex feature extractions underlying sensory perception. Pain is an exception. Its adaptive message, fight or flee, is already available at the first central synapse. We propose that raw consciousness emerged with pain. Eons later the cortical supercomputer began providing complex computational output to the primeval circuitry of conscious pain experience, already operating subcortically.
- 3 November 2025
- Published by Cambridge University Press (CUP) in Behavioral and Brain Sciences
- Vol. 48, e80
Pain and the evolutionary origins of subjective experience
The cerebral neocortex is essential for the complex feature extractions underlying sensory perception. Pain is an exception. Its adaptive message, fight or flee, is already available at the first central synapse. We propose that raw consciousness emerged with pain. Eons later the cortical supercomputer began providing complex computational output to the primeval circuitry of conscious pain experience, already operating subcortically.
- Open Access
- 23 June 2025
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 19, 1594984
Loss-of-consciousness: sources of GABAergic input to the mesopontine tegmental anesthesia area
Exposure of neurons in the brainstem mesopontine tegmental anesthesia area (MPTA) to minute quantities of GABAergic general anesthetics at clinically relevant concentrations is sufficient to induce loss-of-consciousness (LOC), while lesioning this nucleus renders rodents relatively insensitive to these anesthetics delivered systemically. The MPTA thus appears to be a key GABA-receptive target in brain mechanisms of clinical anesthesia. As lesioning the MPTA also affects natural instances of LOC including sleep and fainting, it is of interest to know the source(s) of endogenous GABA present in the MPTA. Here, we used retrograde tracing combined with immunolabeling to locate GABAergic neurons that provide the MPTA with synaptic input. Sources of glycinergic and glutamatergic input were also explored. Abundant GABAergic neurons with axonal projections to the MPTA were found in: (1) deep laminae of the neocortex rostrally, (2) a mesolimbic field ranging from the basal forebrain to the limbic midbrain, and (3) deep cerebellar nuclei and the rostroventromedial medulla (RVM). All three showed ipsilateral predominance. Only modest numbers of glycinergic input neurons were found, mostly in the hindbrain. Glutamatergic sources of MPTA input were mainly in the cortex, the ventral tegmental area and the RVM. The endogenous modulatory input to the MPTA identified here, particularly the GABAergic input, likely plays a significant role in the various natural circumstances that involve LOC. GABAergic anesthetics, in turn, agents that permit pain-free surgery, appear to act by substituting for endogenous GABA in the MPTA and hence co-opting endogenous GABA-receptive brain circuitry related to consciousness and its loss.
- 23 June 2025
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 19, 1594984
Open AccessLoss-of-consciousness: sources of GABAergic input to the mesopontine tegmental anesthesia area
Exposure of neurons in the brainstem mesopontine tegmental anesthesia area (MPTA) to minute quantities of GABAergic general anesthetics at clinically relevant concentrations is sufficient to induce loss-of-consciousness (LOC), while lesioning this nucleus renders rodents relatively insensitive to these anesthetics delivered systemically. The MPTA thus appears to be a key GABA-receptive target in brain mechanisms of clinical anesthesia. As lesioning the MPTA also affects natural instances of LOC including sleep and fainting, it is of interest to know the source(s) of endogenous GABA present in the MPTA. Here, we used retrograde tracing combined with immunolabeling to locate GABAergic neurons that provide the MPTA with synaptic input. Sources of glycinergic and glutamatergic input were also explored. Abundant GABAergic neurons with axonal projections to the MPTA were found in: (1) deep laminae of the neocortex rostrally, (2) a mesolimbic field ranging from the basal forebrain to the limbic midbrain, and (3) deep cerebellar nuclei and the rostroventromedial medulla (RVM). All three showed ipsilateral predominance. Only modest numbers of glycinergic input neurons were found, mostly in the hindbrain. Glutamatergic sources of MPTA input were mainly in the cortex, the ventral tegmental area and the RVM. The endogenous modulatory input to the MPTA identified here, particularly the GABAergic input, likely plays a significant role in the various natural circumstances that involve LOC. GABAergic anesthetics, in turn, agents that permit pain-free surgery, appear to act by substituting for endogenous GABA in the MPTA and hence co-opting endogenous GABA-receptive brain circuitry related to consciousness and its loss.
- 1 January 2025
- Published by Wolters Kluwer Health in Pain
- Vol. 166 (1) , 11-19
Experiencing pain: perspectives of Patrick D. Wall—founding editor of the journal PAIN
Pain is a sensory and emotional experience. How did Pat Wall, founding editor of the journal PAIN and recognized pain guru, view the relation between the brain and the experience of pain? He was certain what it is not. It is not impulses in peripheral nociceptors that light up neurons in a central pain nucleus. Rather, it is a complex “signature” of brain activity normally driven by sensory stimuli, but in the event of pathology also from ectopic sources in injured nerves and associated dorsal root ganglia. Pain signatures are modulated in many ways: suppressed by gate control and descending brain pathways, augmented by peripheral and central sensitization, and massaged by abundant central feedback and feedforward loops. Pain experience is a complex function of a conscious brain. Ultimately, to understand pain is to understand conscious perception.
- 1 January 2025
- Published by Wolters Kluwer Health in Pain
- Vol. 166 (1) , 11-19
Experiencing pain: perspectives of Patrick D. Wall—founding editor of the journal PAIN
Pain is a sensory and emotional experience. How did Pat Wall, founding editor of the journal PAIN and recognized pain guru, view the relation between the brain and the experience of pain? He was certain what it is not. It is not impulses in peripheral nociceptors that light up neurons in a central pain nucleus. Rather, it is a complex “signature” of brain activity normally driven by sensory stimuli, but in the event of pathology also from ectopic sources in injured nerves and associated dorsal root ganglia. Pain signatures are modulated in many ways: suppressed by gate control and descending brain pathways, augmented by peripheral and central sensitization, and massaged by abundant central feedback and feedforward loops. Pain experience is a complex function of a conscious brain. Ultimately, to understand pain is to understand conscious perception.
- Open Access
- 30 December 2024
- Published by Wolters Kluwer Health in Pain
- Vol. 166 (7) , 1549-1564
Molecular and cellular targets of GABAergic anesthetics in the mesopontine tegmentum that enable pain-free surgery
The mesopontine tegmental anesthesia area (MPTA) is a focal brainstem locus which, when exposed to GABAergic agents, induces brain-state transitioning from wakefulness to unconsciousness. Correspondingly, MPTA lesions render animals relatively insensitive to GABAergic anesthetics delivered systemically. Using chemogenetics, we recently identified a neuronal subpopulation within the MPTA whose excitation induces this same pro-anesthetic effect. However, very few of these “effector-neurons” express synaptic γ 2-containing GABAA receptor isoforms and none express extrasynaptic δ-subunit containing receptors, suggesting that they are not the direct cellular target of GABAergic agents. Here we used pharmacological tools in rats to define the molecular target(s) of GABAergics in the MPTA. GABA microinjected into the MPTA at nanomolar concentrations, selective for GABAA δ-Rs, proved to be pro-anesthetic as was blocking GABA reuptake. Likewise, low-concentration gaboxadol/THIP, also selective for GABAA δ-Rs, was effective, whereas benzodiazepines and zolpidem, which selectively target GABAA γ 2-Rs, were not. The GABAergic anesthetics pentobarbital and propofol proved pro-anesthetic when applied to the MPTA at the low concentrations present in the brain after systemic dosing. Glycinergic agonists which are inhibitory, but infective on GABAA δ-Rs, and other non-GABAergic agonists tested, were at most only marginally effective. We conclude that GABAA δ-Rs are the primary molecular target of GABAergic anesthetics in the MPTA. Immunolabeling revealed that this GABAA-R isoform is expressed exclusively by a distinct subpopulation of MPTA “δ-cells” that reside in close apposition to effector neurons. This suggests that during wakefulness, δ-cells serve as inhibitory interneurons which, when silenced by GABAergic agents, disinhibit (excite) the effector-neurons, triggering transition to unconsciousness.
- 30 December 2024
- Published by Wolters Kluwer Health in Pain
- Vol. 166 (7) , 1549-1564
Open AccessMolecular and cellular targets of GABAergic anesthetics in the mesopontine tegmentum that enable pain-free surgery
The mesopontine tegmental anesthesia area (MPTA) is a focal brainstem locus which, when exposed to GABAergic agents, induces brain-state transitioning from wakefulness to unconsciousness. Correspondingly, MPTA lesions render animals relatively insensitive to GABAergic anesthetics delivered systemically. Using chemogenetics, we recently identified a neuronal subpopulation within the MPTA whose excitation induces this same pro-anesthetic effect. However, very few of these “effector-neurons” express synaptic γ 2-containing GABAA receptor isoforms and none express extrasynaptic δ-subunit containing receptors, suggesting that they are not the direct cellular target of GABAergic agents. Here we used pharmacological tools in rats to define the molecular target(s) of GABAergics in the MPTA. GABA microinjected into the MPTA at nanomolar concentrations, selective for GABAA δ-Rs, proved to be pro-anesthetic as was blocking GABA reuptake. Likewise, low-concentration gaboxadol/THIP, also selective for GABAA δ-Rs, was effective, whereas benzodiazepines and zolpidem, which selectively target GABAA γ 2-Rs, were not. The GABAergic anesthetics pentobarbital and propofol proved pro-anesthetic when applied to the MPTA at the low concentrations present in the brain after systemic dosing. Glycinergic agonists which are inhibitory, but infective on GABAA δ-Rs, and other non-GABAergic agonists tested, were at most only marginally effective. We conclude that GABAA δ-Rs are the primary molecular target of GABAergic anesthetics in the MPTA. Immunolabeling revealed that this GABAA-R isoform is expressed exclusively by a distinct subpopulation of MPTA “δ-cells” that reside in close apposition to effector neurons. This suggests that during wakefulness, δ-cells serve as inhibitory interneurons which, when silenced by GABAergic agents, disinhibit (excite) the effector-neurons, triggering transition to unconsciousness.
- 1 September 2024
- Published by Wolters Kluwer Health in Pain
- Vol. 165 (9) , 2135
An alternative perspective on the causes of pain in osteoarthritis of the knee and its persistence after total knee replacement surgery
- 1 September 2024
- Published by Wolters Kluwer Health in Pain
- Vol. 165 (9) , 2135
An alternative perspective on the causes of pain in osteoarthritis of the knee and its persistence after total knee replacement surgery
- Open Access
- 27 December 2023
- Published by Elsevier in Interventional Pain Medicine
- Vol. 3 (1) , 100381
Pain in osteoarthritis: Driven by intrinsic rather than extrinsic joint afferents and why this should impact treatment
- 27 December 2023
- Published by Elsevier in Interventional Pain Medicine
- Vol. 3 (1) , 100381
Open AccessPain in osteoarthritis: Driven by intrinsic rather than extrinsic joint afferents and why this should impact treatment
- 10 July 2023
- Published by H1 Connect
Faculty Opinions recommendation of Gate control of sensory neurotransmission in peripheral ganglia by proprioceptive sensory neurons.
Signal processing within DRGs The authors argue that parvalbumin-expressing primary sensory neurons (PV+ neurons) in the mouse dorsal root ganglion (DRG) gate the flow of noxious signals into the CNS in a manner analogous to that of the famous Gate Control theory of pain. The proposed mechanism is release of a neurotransmitter within the ganglion, rather than synaptic action in the dorsal horn. The released neurotransmitter excites nociceptors via a non-synaptic, apparently paracrine action. This is out-of-the-box thinking. Cell somata in the DRG are generally considered to be no more than metabolic factories tasked with maintaining their huge axons. They are not often thought of as significant contributors to sensory signal processing. The principal evidence given is that genetic ablation of most (~2/3) of the PV+ neurons in the L4DRG increases discharge rates of the residual (~1/3) PV+ neurons, recorded optically in anesthetized animals using GCaMP. This includes ongoing discharge and responsiveness to a variety of mechanical, thermal and chemical stimuli applied to the hindpaw skin. It also renders the mice behaviourally hypersensitive to the corresponding stimuli in the awake state. The authors are noncommittal about how this intra-ganglionic excitation works. One idea, based on observations of Gamper's group (Du et al. 2017 {1}), is that baseline discharge causes DRG cells to release GABA in the ganglion, thus inhibiting spike activity generated ectopically and suppressing pain behaviour. Ablating 2/3 of the GABAergic PV+ neurons might reduce this background GABAegic inhibition, thus exciting the residual 1/3 of PV+ neurons by disinhibition. Another idea was co-release of (excitatory) glutamate, along with GABA, from the PV+ neurons. Several minor caveats should be mentioned. For example: 1) the PV+ neurons recorded from are referred to as "proprioceptors", afferents that monitor joint angle and muscle contraction. But their receptive fields, and the stimuli applied to generate the enhanced discharge, were cutaneous and nociceptive. 2) Changing the membrane potential of DRG somata alters discharge originating from within the DRG, as Du et al. and many others have shown. But the response to stimulation at the sensory ending should not be affected (e.g. Amir & Devor 2003 {2}). 3) Moreover, our group failed to see inhibitory effects of GABA on ectopic discharge originating in DRG neurons (Koplovitch et al. 2018 {3}). 4) Partial nerve injury, the key manipulation used here, is an aspect of many rodent neuropathic pain models. A good deal of evidence based on these models suggests that the mechanism of hypersensitivity is primarily spinal, the same sort of modulation incorporated in the Gate Control theory, and not an exotic intra-ganglionic process. Be that as it may, intra-ganglionic signal processing is a good idea. Despite the fact that DRG afferents are among the most closely studied of all neurons in the nervous system, they exhibit a variety of peculiarities which remain mysterious to this day (Devor 1999 {4}). These include expression of numerous membranal synaptic receptors by DRG cell somata, and the release of neurotransmitters, despite the fact that virtually no synapses occur in DRGs. The suggestion that DRGs process and modify sensory signals, perhaps employing paracrine signalling, is intriguing and deserves continued research investment.
- 10 July 2023
- Published by H1 Connect
Faculty Opinions recommendation of Gate control of sensory neurotransmission in peripheral ganglia by proprioceptive sensory neurons.
Signal processing within DRGs The authors argue that parvalbumin-expressing primary sensory neurons (PV+ neurons) in the mouse dorsal root ganglion (DRG) gate the flow of noxious signals into the CNS in a manner analogous to that of the famous Gate Control theory of pain. The proposed mechanism is release of a neurotransmitter within the ganglion, rather than synaptic action in the dorsal horn. The released neurotransmitter excites nociceptors via a non-synaptic, apparently paracrine action. This is out-of-the-box thinking. Cell somata in the DRG are generally considered to be no more than metabolic factories tasked with maintaining their huge axons. They are not often thought of as significant contributors to sensory signal processing. The principal evidence given is that genetic ablation of most (~2/3) of the PV+ neurons in the L4DRG increases discharge rates of the residual (~1/3) PV+ neurons, recorded optically in anesthetized animals using GCaMP. This includes ongoing discharge and responsiveness to a variety of mechanical, thermal and chemical stimuli applied to the hindpaw skin. It also renders the mice behaviourally hypersensitive to the corresponding stimuli in the awake state. The authors are noncommittal about how this intra-ganglionic excitation works. One idea, based on observations of Gamper's group (Du et al. 2017 {1}), is that baseline discharge causes DRG cells to release GABA in the ganglion, thus inhibiting spike activity generated ectopically and suppressing pain behaviour. Ablating 2/3 of the GABAergic PV+ neurons might reduce this background GABAegic inhibition, thus exciting the residual 1/3 of PV+ neurons by disinhibition. Another idea was co-release of (excitatory) glutamate, along with GABA, from the PV+ neurons. Several minor caveats should be mentioned. For example: 1) the PV+ neurons recorded from are referred to as "proprioceptors", afferents that monitor joint angle and muscle contraction. But their receptive fields, and the stimuli applied to generate the enhanced discharge, were cutaneous and nociceptive. 2) Changing the membrane potential of DRG somata alters discharge originating from within the DRG, as Du et al. and many others have shown. But the response to stimulation at the sensory ending should not be affected (e.g. Amir & Devor 2003 {2}). 3) Moreover, our group failed to see inhibitory effects of GABA on ectopic discharge originating in DRG neurons (Koplovitch et al. 2018 {3}). 4) Partial nerve injury, the key manipulation used here, is an aspect of many rodent neuropathic pain models. A good deal of evidence based on these models suggests that the mechanism of hypersensitivity is primarily spinal, the same sort of modulation incorporated in the Gate Control theory, and not an exotic intra-ganglionic process. Be that as it may, intra-ganglionic signal processing is a good idea. Despite the fact that DRG afferents are among the most closely studied of all neurons in the nervous system, they exhibit a variety of peculiarities which remain mysterious to this day (Devor 1999 {4}). These include expression of numerous membranal synaptic receptors by DRG cell somata, and the release of neurotransmitters, despite the fact that virtually no synapses occur in DRGs. The suggestion that DRGs process and modify sensory signals, perhaps employing paracrine signalling, is intriguing and deserves continued research investment.
- Open Access
- 5 July 2023
- Published by MDPI AG in Preprints.org
Pain in Osteoarthritis: Driven by Intrinsic Rather Than Extrinsic Joint Afferents and Why This Should Impact Treatment
Pain in osteoarthritis (OA) results from erosion of joint cartilage, resulting in bone contacting bone without an intervening cushion. The periosteum, including its nociceptive innervation, ends at the border of the cartilage meaning that there is no extrinsic neuronal pathway between the opposing denuded bone surfaces to carry a bone-on-bone pain signal to the brain. The pain signaling pathway must therefore originate in nociceptive sensory endings within the subchondral bone itself. Selective ablation of this intrinsic nerve pathway, using any of a variety of approaches, is expected to permanently eliminate OA pain.
- 5 July 2023
- Published by MDPI AG in Preprints.org
Open AccessPain in Osteoarthritis: Driven by Intrinsic Rather Than Extrinsic Joint Afferents and Why This Should Impact Treatment
Pain in osteoarthritis (OA) results from erosion of joint cartilage, resulting in bone contacting bone without an intervening cushion. The periosteum, including its nociceptive innervation, ends at the border of the cartilage meaning that there is no extrinsic neuronal pathway between the opposing denuded bone surfaces to carry a bone-on-bone pain signal to the brain. The pain signaling pathway must therefore originate in nociceptive sensory endings within the subchondral bone itself. Selective ablation of this intrinsic nerve pathway, using any of a variety of approaches, is expected to permanently eliminate OA pain.